Ratio Therapeutics

Ratio Therapeutics is a discovery-through-early-clinical-phase pharmaceutical company based in Boston, Massachusetts. The company employs innovative technologies, including its Trillium targeting scaffold, to develop best-in-class targeted radiotherapeutics for cancer treatment. Ratio Therapeutics has assembled an interdisciplinary team of experts and maintains strong intellectual property positions, while also collaborating with major pharmaceutical companies on first-in-human trials.